Chemours Company
CC
Market Cap$4.06B
Close$
$25.40
3.7% downside
Current Fair Value
3.7% downsideOvervalued by 3.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.06 Billion |
|---|---|
| Enterprise Value | $6.90 Billion |
| Dividend Yield | $0.987 (3.62%) |
| Earnings per Share | $-1.6 |
| Beta | 1.65 |
| Outstanding Shares | 148,801,731 |
| Avg 30 Day Volume | 1,838,643 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -17.07 |
|---|---|
| PEG | 23.65 |
| Price to Sales | 0.66 |
| Price to Book Ratio | 6.59 |
| Enterprise Value to Revenue | 1.14 |
| Enterprise Value to EBIT | -146.75 |
| Enterprise Value to Net Income | -29 |
| Total Debt to Enterprise | 0.59 |
| Debt to Equity | 5.48 |
Revenue Sources
No data
ESG Score
No data
About Chemours Company
7,000 employees
CEO: Mark Vergnano The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...